The world's first mRNA vaccine against a deadly disease

Published Date: 15 Mar 2023

A world first: A research team from Tel Aviv University and the Israel Institute of Biology has developed an anti-mRNA drug that is 100% effective against a single type of virus.

Read Full News

Latest News

What Thriving Hospitalists Know About Building Careers

The still-evolving specialty offers advantages for physicians.

What Extreme Athletes Teach Us About Sleep Deprivation

What can a 1000-mile race teach MDs about sleep? Dr Alison Kole shares sleep deprivation insights from ultramarathon racing and gives practical tips for exhausted patients.

Discordant Tissue Findings in Suspected HLH

Hemophagocytic lymphohistiocytosis is a hyperinflammatory syndrome characterized by an exaggerated immune response to a triggering stimulus.

Omalizumab May Ease Inflammation in Chronic Urticaria

In patients with antihistamine-resistant chronic spontaneous urticaria, omalizumab treatment is linked to clinical improvement and reduced systemic inflammatory markers and D-dimer levels.

Pediatric Lung Transplantation Enters a New Era

New CFTR modulators are reshaping pediatric lung transplantation, forcing clinicians to rethink when children should be referred and listed.

CVS Health's Aetna to Streamline Cancer Treatment Approvals

CVS Health's Aetna health insurance unit will cut back next year on the preapprovals it requires for treatment ⁠for cancer patients to only one medical prior authorization...

Todays Updates

Annual Cancer Report Highlights Advances, Funding Threats

A yearly report from the American Association for Cancer Research lauds recent breakthroughs but warns on threatened federal funding changes.

Does Telenursing Improve QOL in Breast Cancer?

A meta-analysis assesses the effect of nurse-led telenursing on the quality of life in women with breast cancer.

Long-Term Results Favor Acalabrutinib Combo in MCL

The 50-month follow-up of the ECHO trial underscores greater benefits with concurrent vs sequential addition of acalabrutinib to bendamustine and rituximab.

Todays Updates

Annual Cancer Report Highlights Advances, Funding Threats

A yearly report from the American Association for Cancer Research lauds recent breakthroughs but warns on threatened federal funding changes.

Does Telenursing Improve QOL in Breast Cancer?

A meta-analysis assesses the effect of nurse-led telenursing on the quality of life in women with breast cancer.

Long-Term Results Favor Acalabrutinib Combo in MCL

The 50-month follow-up of the ECHO trial underscores greater benefits with concurrent vs sequential addition of acalabrutinib to bendamustine and rituximab.

Latest News

The still-evolving specialty offers advantages for physicians.

What can a 1000-mile race teach MDs about sleep? Dr Alison Kole shares sleep deprivation insights from ultramarathon racing and gives practical tips for exhausted patients.

Hemophagocytic lymphohistiocytosis is a hyperinflammatory syndrome characterized by an exaggerated immune response to a triggering stimulus.

In patients with antihistamine-resistant chronic spontaneous urticaria, omalizumab treatment is linked to clinical improvement and reduced systemic inflammatory markers and D-dimer levels.

New CFTR modulators are reshaping pediatric lung transplantation, forcing clinicians to rethink when children should be referred and listed.

CVS Health's Aetna health insurance unit will cut back next year on the preapprovals it requires for treatment ⁠for cancer patients to only one medical prior authorization...

News All Time

Two-Midnight Rule: Key Strategies for Observation Patients

The Two-Midnight Rule has created important clinical and operational strategies for hospitals.

Pediatric Atopic Dermatitis: Biologic Revolution Continues

The pediatric atopic dermatitis treatment landscape expands as new biologics emerge, and researchers ask whether earlier intervention can change the course of disease.

Pediatric Asthma Flares Rise After School Resumes

Asthma flare-ups spike in the weeks after school starts, when viral exposure, allergens, and missed maintenance treatment can converge in children.

AAD Issues Guidelines on Treatment-Refractory Adult Eczema

Experts suggest a more ‘whole person’ differential diagnosis when adults do not respond to atopic dermatitis treatment.

Mast Cell Activation Syndrome: Patients Look for Answers

For patients with unexplained multisystem symptoms, getting answers can mean navigating competing criteria and conflicting information.

SLE Incidence Appears to Peak Later in Men Than in Women

A meta-analysis finds that systemic lupus erythematosus is most often diagnosed among women in their 30s and men in their 60s, with notable differences seen across races and ethnicities.

Clinicians Should Be on Alert for Measles in Adults

Data suggests that infected adults are being hospitalized as often, or more than, children younger than 5 years.

Enhancing Quality of Life for Terminally Ill Veterans

Honoring individualized preferences for end-of-life interventions for veterans is a priority for families and caregivers; this study explores various nonpharmacologic interventions.

US FDA Extends Review Of Exelixis' Cancer Drug

The U.S. Food and Drug Administration has extended the review of Exelixis' experimental colorectal cancer drug combination ⁠by three months, the company said in a filing on...

CDC Issues Alert on Rabies Exposure, Appropriate Treatment

The agency expresses concern that a rise in use of postexposure prophylaxis could indicate a lack of understanding of when to administer the therapy.

Backlogs, Testing Gaps in Medicare AI Prior Auth Pilot

Internal documents show contractor readiness concerns, decision delays, and high non-affirmation rates, while providers report patients waiting for care and payment problems.

Food Allergies Linked to Eating Disorder History

Screening for eating disorders may help clinicians identify when food avoidance in patients with allergies extends beyond necessary dietary restrictions.

Mycobacteria Linked to Worse Lung Transplant Outcomes

In lung transplant recipients, detecting nontuberculous mycobacteria in the first year after a transplant may signal heightened risks for death or a repeat transplant and for chronic graft decline.

Alopecia Areata Consensus Statement Recommends First-Line Rx

An expert consensus panel has offered the first-ever standardized, evidence-based recommendations for the management of alopecia areata, identifying JAK inhibitors as the first-line therapy.

Missing Piece of the Thymus/Immune System Puzzle May Be Age

Researchers took a new tack investigating how the thymus affects immune system function and immunotherapy effectiveness: using aged mice. The results were eye-opening.

Fluticasone Improves Sinusitis Across Disease Profiles

Fluticasone delivered via an exhalation system reduces symptoms and improves quality of life in adults with chronic rhinosinusitis, across inflammatory endotypes and comorbidities, a study shows.

Recommended News For You

Anti-PD-L1 Plus Targeted Agent No Better Than Chemo for Resistant NSCLC

Characterizing metastatic disease during adaptive therapy by using dynamic biomarkers and mathematical modeling.

NP-Led Outreach Ups Cancer Screening in Rural Women Veterans

Heavy Cannabis Use Tied to Increased Head and Neck Cancer Risk

Committee Recommends Canada Not Permit Euthanasia Solely for Mental Illness

Is There a Role for Stimulants in Beating Cancer Fatigue?

Certain surgical gestures during prostate removal linked to better sexual function recovery

Recommended Articles For You

Hematopoietic Resilience and Future Clinical Performance: Mechanisms, Clinical Implications, and Emerging Perspectives 

Critical Care Challenges in Oncologic Emergencies 

The latest research on Iron Binding Capacity: The Little-Known Factor That Could Impact Your Health v 

Protein S-Palmitoylation in Cancer: A Novel Target in Immunotherapy & Treatment 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Distinct results for patients with positive and negative pancreatic cancer who are treated with systemic therapy, chemotherapy, and radiation.

2.

Optimizing Sequencing of BCMA-Directed Therapies in Myeloma

3.

After all, Pulled Myeloma Drug May Help Treat the Illness.

4.

First-Line T-DXd Boosts PFS in HER2-Mutant NSCLC

5.

Breast awareness: What to look for in your self-exam

1.

Epigenetic Signatures for Multi-Cancer Screening

2.

Quality of Life Using Precision Functional Recovery After Organ-Preserving Interventions

3.

Exploring the Mystery of Angiokeratomas on Scrotum: Causes, Symptoms and Treatment

4.

Guidelines for Transfusion Threshold Assessment

5.

Exploring the Potential of Cytologic Atypia in Cancer Diagnosis

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Current Scenario of Cancer- The Incidence of Cancer in Men

2.

Nutrition During Cancer Treatment

3.

Future of Hematology

4.

Oropharyngeal Cancer in Relation to HPV Status

5.

Efficient Management of First line ALK-rearranged NSCLC - Part IV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot